BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AnaSpec, Inc. Highlights Beta-Amyloid (1-40) Peptides


6/14/2012 1:50:17 PM

Fremont CA – June 14, 2012 -- ß-Amyloid (1-40) together with ß-Amyloid (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs, with Ab (1-42) being more neurotoxic. These undergo post-secretory aggregation and deposition in the Alzheimer’s diseased brain.1-5

AnaSpec, EGT Group is pleased to be a provider of a large collection of ß-Amyloid (1-40) peptides:

• Native sequences – human and mouse/rat sequences (unless otherwise specified, sequences are human in origin)

• Single or multiple amino acid substitution sequences, e.g. S26C

• Biotin labeled sequences – N or C terminally labeled, with or without linker

• Dye labeled sequences – HiLyte Fluor™ or classic dye labeled

• ClearPoint™ heavy-isotope labeled sequences

• Shorter sequences that end on the 40th amino acid and analog

• HFIP treated ß-Amyloid (1-40)

References:

1. Masters, CL. et al. Proc Natl Acad Sci USA 82, 4245 (1985).

2. Yankner, BA. Neuron 16, 921 (1996).

3. Geula, C. et al. Nat Med 4, 827 (1998).

4. Shin, R. et al. J Neurosci 17, 8187 (1997).

5. Suzuki, N. et.al. Science 264, 1336 (1994).

For more information, please visit http://www.anaspec.com/products/promotions.asp?id=101&col=2&row=2

AnaSpec, EGT Group

AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->